Home/Filings/4/0001415889-24-025148
4//SEC Filing

Ndu Adora 4

Accession 0001415889-24-025148

CIK 0001070494other

Filed

Oct 14, 8:00 PM ET

Accepted

Oct 15, 6:05 PM ET

Size

7.0 KB

Accession

0001415889-24-025148

Insider Transaction Report

Form 4
Period: 2024-10-12
Ndu Adora
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2024-10-12+4,38115,414 total
  • Exercise/Conversion

    Restricted Stock Units

    2024-10-124,3810 total
    Common Stock (4,381 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock.
  • [F2]The restricted stock units vested in two equal annual installments on each of October 12, 2023 and October 12, 2024.

Issuer

ACADIA PHARMACEUTICALS INC

CIK 0001070494

Entity typeother

Related Parties

1
  • filerCIK 0001865210

Filing Metadata

Form type
4
Filed
Oct 14, 8:00 PM ET
Accepted
Oct 15, 6:05 PM ET
Size
7.0 KB